These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 37607734)

  • 21. CRISPR/Cas gene-editing technology and its advances in dentistry.
    Chavez-Granados PA; Manisekaran R; Acosta-Torres LS; Garcia-Contreras R
    Biochimie; 2022 Mar; 194():96-107. PubMed ID: 34974144
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Advanced Nanotheranostics of CRISPR/Cas for Viral Hepatitis and Hepatocellular Carcinoma.
    Kong H; Ju E; Yi K; Xu W; Lao YH; Cheng D; Zhang Q; Tao Y; Li M; Ding J
    Adv Sci (Weinh); 2021 Dec; 8(24):e2102051. PubMed ID: 34665528
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recent Advances in the Application of CRISPR/Cas9 Gene Editing System in Poultry Species.
    Khwatenge CN; Nahashon SN
    Front Genet; 2021; 12():627714. PubMed ID: 33679892
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficient introduction of specific homozygous and heterozygous mutations using CRISPR/Cas9.
    Paquet D; Kwart D; Chen A; Sproul A; Jacob S; Teo S; Olsen KM; Gregg A; Noggle S; Tessier-Lavigne M
    Nature; 2016 May; 533(7601):125-9. PubMed ID: 27120160
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Progress and challenges in CRISPR-mediated therapeutic genome editing for monogenic diseases.
    Konishi CT; Long C
    J Biomed Res; 2020 Nov; 35(2):148-162. PubMed ID: 33402545
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gene Editing and Genetic Lung Disease. Basic Research Meets Therapeutic Application.
    Alapati D; Morrisey EE
    Am J Respir Cell Mol Biol; 2017 Mar; 56(3):283-290. PubMed ID: 27780343
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The promise of CRISPR/Cas9 technology in diabetes mellitus therapy: How gene editing is revolutionizing diabetes research and treatment.
    Cheng Y; Wang H; Li M
    J Diabetes Complications; 2023 Aug; 37(8):108524. PubMed ID: 37295292
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Application of CRISPR/Cas9 gene editing technique in the study of cancer treatment.
    Jiang C; Meng L; Yang B; Luo X
    Clin Genet; 2020 Jan; 97(1):73-88. PubMed ID: 31231788
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CRISPR-Cas9, A Promising Therapeutic Tool for Cancer Therapy: A Review.
    Akram F; Ikram Ul Haq ; Ahmed Z; Khan H; Ali MS
    Protein Pept Lett; 2020; 27(10):931-944. PubMed ID: 32264803
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Advances in Sphingolipidoses: CRISPR-Cas9 Editing as an Option for Modelling and Therapy.
    Santos R; Amaral O
    Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31771289
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Impact of CRISPR/Cas9 Technology on Cardiac Research: From Disease Modelling to Therapeutic Approaches.
    Motta BM; Pramstaller PP; Hicks AA; Rossini A
    Stem Cells Int; 2017; 2017():8960236. PubMed ID: 29434642
    [TBL] [Abstract][Full Text] [Related]  

  • 32. RNAi therapeutics for diseases involving protein aggregation: fazirsiran for alpha-1 antitrypsin deficiency-associated liver disease.
    Strnad P; San Martin J
    Expert Opin Investig Drugs; 2023; 32(7):571-581. PubMed ID: 37470509
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Application of CRISPR-Cas9 gene editing for congenital heart disease.
    Seok H; Deng R; Cowan DB; Wang DZ
    Clin Exp Pediatr; 2021 Jun; 64(6):269-279. PubMed ID: 33677855
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genome Editing Approaches with CRISPR/Cas9 for Cancer Treatment: Critical Appraisal of Preclinical and Clinical Utility, Challenges, and Future Research.
    Chira S; Nutu A; Isacescu E; Bica C; Pop L; Ciocan C; Berindan-Neagoe I
    Cells; 2022 Sep; 11(18):. PubMed ID: 36139356
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CRISPR/Cas9 therapeutics for liver diseases.
    Aravalli RN; Steer CJ
    J Cell Biochem; 2018 Jun; 119(6):4265-4278. PubMed ID: 29266637
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of heritable diseases using CRISPR: Hopes, fears, and reality.
    Kofler N; Kraschel KL
    Semin Perinatol; 2018 Dec; 42(8):515-521. PubMed ID: 30420296
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CRISPR/Cas system: A game changing genome editing technology, to treat human genetic diseases.
    Hussain W; Mahmood T; Hussain J; Ali N; Shah T; Qayyum S; Khan I
    Gene; 2019 Feb; 685():70-75. PubMed ID: 30393194
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An exciting time for genome editing: an interview with David R. Liu.
    Zhao W; Zhao KT
    Natl Sci Rev; 2019 May; 6(3):452-454. PubMed ID: 34691894
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CRISPR-Cas9 for medical genetic screens: applications and future perspectives.
    Xue HY; Ji LJ; Gao AM; Liu P; He JD; Lu XJ
    J Med Genet; 2016 Feb; 53(2):91-7. PubMed ID: 26673779
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rapid Disruption of Genes Specifically in Livers of Mice Using Multiplex CRISPR/Cas9 Editing.
    Pankowicz FP; Barzi M; Kim KH; Legras X; Martins CS; Wooton-Kee CR; Lagor WR; Marini JC; Elsea SH; Bissig-Choisat B; Moore DD; Bissig KD
    Gastroenterology; 2018 Dec; 155(6):1967-1970.e6. PubMed ID: 30170115
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.